Key Drivers
- Revenue Scale
- Debt Burden
- Thin Profitability
AIAI Summary
Chemours is now primarily a balance-sheet and execution story rather than a simple chemicals cyclical: despite validated niche wins like Opteon and modest operating improvement, high debt, negative earnings, and inconsistent free cash flow mean the stock only works if management quickly converts these wins into durable cash generation before refinancing and leverage risks dominate.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Revenue Scale
- •Debt Burden
- •Thin Profitability
CC has meaningful revenue scale and adequate liquidity, but thin margins, heavy debt, and ongoing losses/uneven cash flow keep the investment case high risk despite some operating improvement.
Price Behavior
Key Price Behavior Insights:
- •Failed breakout
- •Key support hold
- •Weak momentum
Over the last month, CC spiked to $27.84 but quickly faded back to $23.13, leaving momentum flat and making $22.33 the key support to hold before any renewed move higher.
Sharp rally to $27.84 quickly reversed back near $23.13
Sentiment & News
Key News Insights:
- •Earnings beat
- •Revenue miss
- •Guidance support
Chemours delivered a mixed Q1 2026 update—earnings beat expectations and pricing/guidance supported EBITDA, but revenue missed and losses widened as volumes weakened, while segment execution and industry tailwinds offer some offset.
Mixed results suggest limited near-term upside, but pricing strength, continued dividends, and market tailwinds should help support CC
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings